Cauble & Harre Wealth Management Inc. Buys Shares of 138,381 Enovix Corporation $ENVX

Posted by Brenda Bartman on May 16th, 2026

Cauble & Harre Wealth Management Inc. bought a new stake in Enovix Corporation (NASDAQ:ENVX – Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 138,381 shares of the company’s stock, valued at approximately $1,012,000. Enovix comprises approximately 0.8% of Cauble & Harre Wealth Management Inc.’s holdings, making the stock its 27th biggest holding.

A number of other large investors also recently bought and sold shares of the stock. Oppenheimer & Co. Inc. lifted its position in Enovix by 7.0% in the fourth quarter. Oppenheimer & Co. Inc. now owns 425,259 shares of the company’s stock valued at $3,109,000 after buying an additional 27,747 shares during the last quarter. Wealthfront Advisers LLC acquired a new position in Enovix during the fourth quarter worth $79,000. M&T Bank Corp lifted its stake in Enovix by 12.0% during the fourth quarter. M&T Bank Corp now owns 20,002 shares of the company’s stock worth $146,000 after purchasing an additional 2,139 shares in the last quarter. McGowan Group Asset Management Inc. lifted its stake in Enovix by 6.0% during the fourth quarter. McGowan Group Asset Management Inc. now owns 384,123 shares of the company’s stock worth $2,808,000 after purchasing an additional 21,751 shares in the last quarter. Finally, Vanguard Group Inc. lifted its stake in Enovix by 10.9% during the fourth quarter. Vanguard Group Inc. now owns 17,760,708 shares of the company’s stock worth $129,831,000 after purchasing an additional 1,747,145 shares in the last quarter. Institutional investors and hedge funds own 50.92% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have commented on the company. Craig Hallum decreased their price target on Enovix from $10.00 to $8.00 and set a “buy” rating on the stock in a research note on Thursday. Wells Fargo & Company set a $6.00 price target on Enovix in a research note on Thursday, March 12th. Weiss Ratings restated a “sell (e+)” rating on shares of Enovix in a research note on Friday, April 10th. Bank of America assumed coverage on shares of Enovix in a research report on Thursday, March 12th. They set a “neutral” rating and a $6.00 price target on the stock. Finally, Benchmark reduced their price target on shares of Enovix from $25.00 to $15.00 and set a “buy” rating on the stock in a research report on Thursday. Seven investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat, Enovix presently has an average rating of “Moderate Buy” and an average price target of $12.64.

Read Our Latest Stock Analysis on ENVX

Enovix Stock Down 3.0%

Shares of ENVX opened at $6.11 on Friday. The stock has a market capitalization of $1.33 billion, a PE ratio of -7.36 and a beta of 2.24. The company has a debt-to-equity ratio of 1.90, a quick ratio of 8.13 and a current ratio of 8.34. Enovix Corporation has a 1 year low of $4.61 and a 1 year high of $16.49. The company’s 50-day simple moving average is $5.82 and its 200-day simple moving average is $7.10.

Enovix (NASDAQ:ENVX – Get Free Report) last announced its quarterly earnings data on Wednesday, May 13th. The company reported ($0.14) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.15) by $0.01. The business had revenue of $7.60 million for the quarter, compared to analysts’ expectations of $6.95 million. Enovix had a negative return on equity of 63.25% and a negative net margin of 499.64%.The company’s revenue for the quarter was up 49.1% compared to the same quarter last year. During the same period last year, the firm earned ($0.15) earnings per share. Enovix has set its Q2 2026 guidance at -0.170–0.130 EPS. Analysts forecast that Enovix Corporation will post -0.81 earnings per share for the current fiscal year.

Enovix News Summary

Here are the key news stories impacting Enovix this week:

Positive Sentiment: Enovix’s Q1 results beat revenue expectations and the company reported a smaller-than-expected loss, while management highlighted revenue growth and strategic progress on the earnings call. Enovix Corp (ENVX) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic Alignments
Positive Sentiment: Unusually heavy call option activity suggests some traders are betting on a rebound in Enovix shares. Enovix (NASDAQ:ENVX) Price Target Cut to $21.00 by Analysts at Oppenheimer
Neutral Sentiment: Oppenheimer, Benchmark, Craig Hallum, and TD Cowen all reduced their price targets on Enovix, but most still kept constructive ratings, signaling lower valuation expectations rather than a full thesis change. Enovix (NASDAQ:ENVX) Given New $15.00 Price Target at Benchmark Enovix (NASDAQ:ENVX) Price Target Lowered to $8.00 at Craig Hallum Enovix (NASDAQ:ENVX) Price Target Cut to $7.00 by Analysts at TD Cowen
Negative Sentiment: Investors are also focused on Enovix’s widening losses and the uncertain timeline for commercialization, which appeared to weigh on the stock after earnings. Enovix sinks as losses widen; commercialization timeline remains in focus

About Enovix

(Free Report)

Enovix Corporation (NASDAQ: ENVX) develops and manufactures advanced lithium-ion battery cells with a patented three-dimensional silicon-anode architecture. The company’s core focus is on delivering high energy density, improved safety, and longer cycle life compared to conventional graphite-based cells. Enovix’s technology targets a range of applications, including consumer electronics, wearable devices, electric vehicles and stationary energy storage systems.

Founded in 2011 and headquartered in Fremont, California, Enovix has built pilot production capability and is scaling up manufacturing capacity to meet growing demand.